In the RM-ANOVA analysis, changes of ACE levels or ACE/ACE2 ratios over 12 M were positively associated with baseline RF and FMD in the full cohort and with baseline RF in the RA subset. The gene discussed is ACE; the disease is rheumatoid arthritis.